Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

730 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological inhibition of N-Acylethanolamine acid amidase (NAAA) mitigates intestinal fibrosis through modulation of macrophage activity.
Nanì MF, Pagano E, De Cicco P, Lucariello G, Cattaneo F, Tropeano FP, Cicia D, Amico R, Raucci F, Ercolano G, Maione F, Rinaldi MM, Esposito F, Ammendola R, Luglio G, Capasso R, Makriyannis A, Petrosino S, Borrelli F, Romano B, Izzo AA. Nanì MF, et al. Among authors: amico r. J Crohns Colitis. 2024 Aug 30:jjae132. doi: 10.1093/ecco-jcc/jjae132. Online ahead of print. J Crohns Colitis. 2024. PMID: 39211986
Weight and metabolic changes with long-acting cabotegravir and rilpivirine or bictegravir/emtricitabine/tenofovir alafenamide.
Tan DHS, Antinori A, Eu B, Galindo Puerto MJ, Kinder C, Sweet D, Dam CNV, Sutton K, Sutherland-Phillips D, Berni A, Zhang F, Urbaityte R, Baugh B, Spreen W, Wyk JV, Garges HP, Patel P, Batterham R, D'amico R. Tan DHS, et al. Among authors: d amico r. J Acquir Immune Defic Syndr. 2024 Dec 16. doi: 10.1097/QAI.0000000000003584. Online ahead of print. J Acquir Immune Defic Syndr. 2024. PMID: 39676239
Declaration of Computational Neurosurgery.
Di Ieva A, Suero Molina E, Somerville MA, Beheshti A, Staartjes VE, Serra C, Theodore N, Elliott JM, Wesselink EO, Russo C, Pilitsis JG, Bennett CC, Wu S, Hammond FM, Lozano AM, Cusimano MD, Davidson JM, Castellano JF, Okonkwo DO, Arefan D, Lee CC, Zanier O, Da Mutten R, Matula C, Rutka JT, Pease M, Liu S, Stummer W, Matulionyte R, Yang H, Yuwen C, Cheng X, Fan H, Wang X, Ge Z, Cepeda S, Sheehan JP, Yang JY, Hamer RP, Cohen-Gadol A, Hansford JR, Savage G, Sowman PF, Stewart C, Kateb B, Sherif C, Perperidis A, Guller A, Hanft S, D'Amico RS, Sav A, Cong C, Song Y, Nicolosi F, Wiedmann MKH, Barone DG, Noorani I, Magnussen J, Krieg SM, Meling TR, De Ridder D, Lawton MT, Rosenfeld JV. Di Ieva A, et al. Among authors: d amico rs. Adv Exp Med Biol. 2024;1462:11-20. doi: 10.1007/978-3-031-64892-2_2. Adv Exp Med Biol. 2024. PMID: 39523257
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.
Mussini C, Cazanave C, Adachi E, Eu B, Alonso MM, Crofoot G, Chounta V, Kolobova I, Sutton K, Sutherland-Phillips D, Urbaityte R, Ehmann A, Scherzer J, de Los Rios P, D'Amico R, Spreen W, van Wyk J. Mussini C, et al. Among authors: d amico r. AIDS Behav. 2024 Oct 8. doi: 10.1007/s10461-024-04490-0. Online ahead of print. AIDS Behav. 2024. PMID: 39375290
730 results